BioCentury
ARTICLE | Clinical News

EP217609: Additional Phase I data

December 6, 2010 8:00 AM UTC

Additional data from a French Phase I trial in 36 healthy volunteers showed that a single IV bolus injection of EP217609 achieved stable anticoagulation during 90 minutes. Subsequent administration of...